MARKET

HZNP

HZNP

Horizon Therapeutics Plc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

27.28
+0.22
+0.81%
After Hours: 27.28 0 0.00% 16:37 10/14 EDT
OPEN
27.09
PREV CLOSE
27.06
HIGH
27.52
LOW
26.99
VOLUME
889.24K
TURNOVER
--
52 WEEK HIGH
29.44
52 WEEK LOW
16.56
MARKET CAP
5.09B
P/E (TTM)
109.73
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of HZNP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

HZNP News

  • Horizon Therapeutics' Phase 3 trial finds 'significant benefit' of teprotumumab
  • seekingalpha.3d ago
  • New Data from Teprotumumab Phase 3 OPTIC Study Shows Significantly Reduced Double Vision and Improved Quality of Life for People with Active Thyroid Eye Disease
  • Business Wire.3d ago
  • For World Sight Day, Horizon and Prevent Blindness Are Calling on the Thyroid Eye Disease (TED) Community to Put Vision First
  • Business Wire.4d ago
  • Horizon Therapeutics plc to Release Third-Quarter 2019 Financial Results and Host Webcast on Nov. 6, 2019
  • Business Wire.5d ago

More

Industry

Pharmaceuticals
-0.01%
Pharmaceuticals & Medical Research
+0.09%

Hot Stocks

Name
Price
%Change

About HZNP

Horizon Therapeutics plc, formerly Horizon Pharma plc, is a rare disease biopharmaceutical company. The Company is focused on researching, developing and commercializing medicines that address needs for people impacted by rare and rheumatic diseases. The Company markets approximately 10 medicines, of which 6 are for rare and rheumatic diseases. The Company's marketed medicines are ACTIMMUNE (interferon gamma-1b), BUPHENYL (sodium phenylbutyrate) Tablets and Powder, DUEXIS (ibuprofen/famotidine), KRYSTEXXA (pegloticase), PENNSAID (diclofenac sodium topical solution) 2% weight per weight (w/w), or PENNSAID 2%, PROCYSBI (cysteamine bitartrate) delayed-release capsules, QUINSAIR (aerosolized form of levofloxacin), RAVICTI (glycerol phenylbutyrate) Oral Liquid, RAYOS (prednisone) delayed-release tablets and VIMOVO (naproxen/esomeprazole magnesium).
More

Webull offers Horizon Therapeutics PLC (HZNP) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.